Skip to main content

Unveiling SmallCap Biotech Stocks to Watch: INBS, CERS, HIMS

This Article Examines SmallCap Biotech Stocks Opportunities for Potential Growth in the Medical Sector.

Intelligent Bio Solutions Inc (NASDAQ:INBS) - It is a medical technology company that is involved in the development of non-invasive, fast, and intelligent testing solutions. Its flagship product is the Intelligent Fingerprinting Drug Screening System which has had a revolutionizing effect on portable testing through fingerprinting sweat analysis space.

On June 20 the company announced that it had been granted the second progress payment to the tune of $1.43 million in relation to the scientific grant that had been awarded to the company worth $4.7 million in 2021. The latest tranche of the grant brought the total grant received by Intelligent Bio Solutions to $3.25 million.

The grant had been made by the Department of Industry, Science, Energy and Resources’ Modern Manufacturing Initiative of the Australian Federal Government and is known as the Medical Products Priority Grant.

Cerus Corporation (NASDAQ:CERS) - The company is focused on safeguarding the worldwide blood supply and is looking to turn into the world's leading global blood products entity. It is based out of Concord in California and develops and also supplies pathogen-protected blood components as well as technologies to hospitals and blood centers, which need safe blood for its patients.

On June 5, it was announced that the company had got an additional $8.7 million contract amendment to the originally decided upon $9.1 million from the United States Department of Defense (DoD) Industrial Base Analysis and Sustainment (IBAS) program. As part of the program, the company would be involved in developing pathogen-reduced lyophilized cryoprecipitate, for treating bleeding caused by trauma.

Hims & Hers Health Inc (NYSE:HIMS) - The company is involved in operating a telehealth platform that is involved in connecting consumers to licensed healthcare practitioners. Additionally, Hims & Hers Health Inc also offers a wide array of health and wellness services and products. All those products and services could be purchased by consumers directly through its website or its mobile app.

The company announced on June 13 the launch of its latest hair care offering for women. The new brand is the Hair Blends line and it would provide access to certain formulations which had been created in such a way so that women could benefit from more personalized options for treating hair loss.



Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content.“TSR” is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. “TSR” authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. “TSR” has not been compensated to produce content related to “Any Companies” appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.